Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Journal of Microscopy|November 2, 2004
Crystal orientation mapping of NiO grown on cube textured Ni tapesT G Woodcock, J S Abell, J Eickemeyer, et al.
Clinical Pharmacology and Therapeutics|January 1, 1981
Verapamil disposition in liver disease and intensive-care patients: kinetics, clearance, and apparent blood flow relationshipsB G Woodcock, I Rietbrock, H F Vöhringer, et al.
Journal of Cardiovascular Pharmacology|May 1, 1984
The ergoloid mesylate dihydroergotoxine: radioimmunoassay measurements on plasma and blood-pressure-lowering activityB G Woodcock, W D Habedank, W Loh, et al.
Clinical Pharmacology and Therapeutics|November 1, 1982
Dihydroergotoxine kinetics in healthy men after intravenous and oral administrationB G Woodcock, W Loh, W D Habedank, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Absorption kinetics of dihydroergotoxine following oral administration to manB G Woodcock, N Rietbrock, W Loh, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Effect of D,L-verapamil, verapamil enantiomers and verapamil metabolites on the binding of vincristine to alpha 1-acid glycoproteinB G Woodcock, M S Abdel-Rahman, F Wosch, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitorS Alsalameh, M Burian, G Mahr, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 25, 2024
Alleviation of severe chronic arthritic pain using polyvalent immunoglobulins (KMP01): Two case reportsBarry G Woodcock, Peter Braun, Martin Gasser, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 11, 2018
Risk of tumor progression in colon carcinoma resection and perioperative prophylaxis with polyvalent immunoglobulins - per aspera ad astraReinhard Lissner, Martin Gasser, Anna M Waaga-Gasser, et al.
Pageof 9